Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:BIND_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
BIND-014
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
metastatic castration-resistant prostate cancer |
| gptkbp:mechanismOfAction |
delivers docetaxel to tumor cells
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
prostate-specific membrane antigen
|
| gptkbp:bfsParent |
gptkb:Bind_Therapeutics
gptkb:BIND_Therapeutics |
| gptkbp:bfsLayer |
7
|